These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1589629)

  • 1. [Severe community-acquired pneumopathy. What initial antibiotics to use?].
    Prud'homme A
    Rev Mal Respir; 1992; 9 Suppl 1():R45-8. PubMed ID: 1589629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactam antibiotics in lower respiratory tract infections.
    Schreiner A
    Scand J Infect Dis Suppl; 1984; 42():129-34. PubMed ID: 6597558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic strategy in lower respiratory infections in children].
    Gendrel D
    Rev Prat; 1996 Nov; 46(17):2099-103. PubMed ID: 8978166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lower tract infections as potential indication for therapy with macrolides].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant respiratory pathogens and extended-spectrum antibiotics.
    Pichichero ME
    Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Lode H
    Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
    Furuno JP; Metlay JP; Harnett JP; Wilson J; Langenberg P; McGregor JC; Zhu J; Perencevich EN
    Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):1-9. PubMed ID: 16136615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study.
    Zafar A; Hussain Z; Lomama E; Sibille S; Irfan S; Khan E
    J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial resistance to antibiotics in acute respiratory infections (ARIs).
    López-Antuñano FJ; Silva-Sánchez J
    Arch Med Res; 1997; 28(2):195-203. PubMed ID: 9204608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriological aspects of infections of the upper respiratory tract.
    Kallings LO
    Scand J Infect Dis Suppl; 1983; 39():9-13. PubMed ID: 6580737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of empirical treatment with antibiotics in community acquired lung diseases].
    Dolmann AL; Forti IN; Bernabó JG
    Medicina (B Aires); 1989; 49(1):14-20. PubMed ID: 2698435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.